News

New Clinical Trial Data Bring Hope for Metastatic Triple-Negative Breast Cancer

Jun 25, 2026 in Breast Cancer

How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care

Jun 25, 2026

How Drugmaker Eisai Is Working to Expand Treatment Options for People With Cancer: A Conversation With Oncology Leader Dr. Corina Dutcus

Jun 25, 2026

Taking Kisqali Earlier Helps Prevent Recurrence For Patients With HR+ Breast Cancer Regardless of Subtype

Jun 24, 2026 in Breast Cancer

'A Watershed Moment': Revolution Medicines Chief Development Officer Dr. Alan Sandler On The Breakthrough Giving New Hope in Pancreatic Cancer

Jun 24, 2026

FDA Approves First-of-its-Kind Drug For Advanced Prostate Cancer With Common PTEN Deficiency Mutation

Jun 19, 2026 in Prostate Cancer

When Myeloma Returns, a New Treatment Is Changing the Odds

Jun 19, 2026 in Multiple Myeloma

A Conversation With Biotech Firm Erasca's Chief Medical Officer On What Patients Should Know About the Growing Momentum Behind A New Class Of Oncology Drugs

Jun 19, 2026

'If Our Innovation Doesn't Reach the Patient, Then What Are We Doing?' Drugmaker Bayer's Tara Frenkl On The Company's Patient-First Oncology Mission

Jun 17, 2026

A New Drug Cuts the Risk of Early-Stage Lung Cancer Coming Back by 83%

Jun 16, 2026 in Lung Cancer

Johnson & Johnson’s Mark Wildgust on Putting Patients First in Cancer Care

Jun 16, 2026 in Prostate Cancer

For High-Risk Lymphoma, Adding Targeted Drugs Tafasitamab And Lenalidomide To Standard Treatment Keeps Cancer Controlled For Longer

Jun 15, 2026 in Non-Hodgkin Lymphoma